Clinical Trial Update: Dabigatran in Patients With Atrial Fibrillation and Mitral Biological Prostheses [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating the use of dabigatran in patients with atrial fibrillation and mitral valve disease with biological prostheses; current…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Mitral Valve Insufficiency
• Mitral Valve Stenosis

Drugs mentioned

• Dabigatran (Dabigatran etexilate)

Snippet

Sponsor: Research Institute for Complex Problems of Cardiovascular Diseases, Russia | Conditions: Mitral Valve Stenosis and Insufficiency, Atrial Fibrillation | Phase 4 | Status: UNKNOWN